Skip to main content

Table 2 Participant attitudes about PGT, HDGC, and quality of life (n = 21)

From: Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome

 

n (%)

Had you heard about PGD prior to participating in this survey?

 Yes

14 (66.7)

 No

7 (33.3)

Have you previously considered using PGD?

 Yes

3 (14.3)

 No

16 (76.2)

 Missing

2 (9.5)

Level of interest in learning more about PGD

 Not interested

7 (33.3)

 Uncertain

0 (0)

 Somewhat interested

7 (33.3)

 Very interested

7 (33.3)

Do you believe it is an acceptable practice for healthcare providers to inform individuals who have CDH1 gene mutations about the availability of PGD?

 Yes

19 (90.5)

 No

2 (9.5)

In general, do you believe that PGD is acceptable for conditions that occur during childhood?

 Yes

16 (76.2)

 No

4 (19.0)

 Missing

1 (4.8)

Do you believe that PGD is acceptable for families with CDH1 gene mutations?

 Yes

16 (76.2)

 No

4 (19.0)

 Missing

1 (4.8)

How often do you worry about your chances of developing gastric and/or breast cancer (again)?

 Not at all/ Rarely

7 (33.3)

 Sometimes

5 (23.8)

 Often

7 (33.3)

 Almost all the time

2 (9.5)

Do you experience guilt related to HDGC syndrome affecting your family members?

 Yes

12 (57.1)

 No

9 (42.9)

On a scale of 1 (not severe) to 10 (most severe), how severely has HDGC syndrome affected your overall health and well-being? (M ± SD)

6.0 ± 2.7;

range: 2–10

  1. Note that because the original survey used the terminology “preimplantation genetic diagnosis; PGD,” this language has been retained in the item wording